Catalyst Pharmaceuticals Net Profit Margin 2006-2020 | CPRX

Catalyst Pharmaceuticals net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Catalyst Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.12B $0.04B 35.00%
2020-03-31 $0.12B $0.04B 36.13%
2019-12-31 $0.10B $0.03B 31.37%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.307B $0.102B
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.575B 44.69
Takeda Pharmaceutical (TAK) Japan $56.245B 9.80
Astellas Pharma (ALPMY) Japan $27.759B 14.07
Eisai (ESALY) Japan $27.124B 22.92
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.973B 24.88
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.092B 45.81
Grifols, S.A (GRFS) Spain $11.929B 14.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $8.967B 34.72
IPSEN SA ADR (IPSEY) France $8.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.931B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.908B 13.08
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.629B 41.99
United Therapeutics (UTHR) United States $4.486B 10.37
Arrowhead Pharmaceuticals (ARWR) United States $4.405B 0.00
Evotec AG (EVTCY) Germany $4.022B 139.60
ChemoCentryx (CCXI) United States $3.775B 0.00
FibroGen (FGEN) United States $3.715B 0.00
Hypermarcas (HYPMY) Brazil $3.329B 12.24
Sage Therapeutics (SAGE) United States $3.177B 0.00
PTC Therapeutics (PTCT) United States $3.165B 0.00
Nektar Therapeutics (NKTR) United States $2.968B 0.00
Pacira BioSciences (PCRX) United States $2.570B 67.55
Revolution Medicines (RVMD) United States $2.294B 0.00
Xencor (XNCR) United States $2.220B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.098B 10.16
Corcept Therapeutics (CORT) United States $2.011B 18.52
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.860B 0.00
Cronos Group (CRON) Canada $1.753B 0.00
USANA Health Sciences (USNA) United States $1.548B 14.58
Ironwood Pharmaceuticals (IRWD) United States $1.439B 9.99
Trillium Therapeutics (TRIL) Canada $1.398B 0.00
Heron Therapeutics (HRTX) United States $1.346B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.163B 11.09
Indivior (INVVY) United States $1.152B 14.27
Karyopharm Therapeutics (KPTI) United States $1.073B 0.00
Esperion Therapeutics (ESPR) United States $1.034B 0.00
Translate Bio (TBIO) United States $1.010B 0.00
Zogenix (ZGNX) United States $0.994B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.946B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.919B 572.25
Vectura Group (VEGPF) United Kingdom $0.828B 0.00
Endo (ENDP) Ireland $0.758B 1.12
VAXART, INC (VXRT) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.719B 0.00
ImmunoGen (IMGN) United States $0.628B 0.00
Tilray (TLRY) Canada $0.617B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.607B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.595B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.575B 0.00
Aerie Pharmaceuticals (AERI) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.545B 0.00
Siga Technologies (SIGA) United States $0.537B 57.25
Radius Health (RDUS) United States $0.527B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.515B 0.00
Flexion Therapeutics (FLXN) United States $0.513B 0.00
Ocular Therapeutix (OCUL) United States $0.479B 0.00
Ardelyx (ARDX) United States $0.468B 0.00
Altimmune (ALT) United States $0.434B 0.00
TherapeuticsMD (TXMD) United States $0.430B 0.00
Harpoon Therapeutics (HARP) United States $0.427B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.405B 0.00
Organogenesis Holdings (ORGO) United States $0.405B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.388B 19.35
Redhill Biopharma (RDHL) Israel $0.360B 0.00
Akebia Therapeutics (AKBA) United States $0.360B 0.00
MEI Pharma (MEIP) United States $0.351B 0.00
DURECT (DRRX) United States $0.343B 0.00
PROFOUND MEDICL (PROF) Canada $0.343B 0.00
Innate Pharma SA (IPHYF) France $0.298B 0.00
IMV INC (IMV) Canada $0.297B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
Menlo Therapeutics (VYNE) United States $0.278B 0.00
Jounce Therapeutics (JNCE) United States $0.278B 13.16
Xeris Pharmaceuticals (XERS) United States $0.274B 0.00
Lannett Co Inc (LCI) United States $0.246B 5.71
Rafael Holdings (RFL) United States $0.245B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Nature's Sunshine Products (NATR) United States $0.226B 22.25
KalVista Pharmaceuticals (KALV) United States $0.225B 0.00
Nivalis Therapeutics (ALPN) United States $0.209B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.206B 0.00
Otonomy (OTIC) United States $0.195B 0.00
CASI Pharmaceuticals (CASI) United States $0.190B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.189B 0.00
Heat Biologics (HTBX) United States $0.184B 0.00
OptiNose (OPTN) United States $0.179B 0.00
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
Aquestive Therapeutics (AQST) United States $0.163B 0.00
CTI BioPharma (CTIC) United States $0.158B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.152B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.128B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.127B 0.00
Champions Oncology (CSBR) United States $0.118B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.110B 0.00
Aclaris Therapeutics (ACRS) United States $0.110B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Lipocine (LPCN) United States $0.093B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Biomerica (BMRA) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.078B 0.00
ElectroCore (ECOR) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.067B 0.00
Novan (NOVN) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.058B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.056B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.18
SCYNEXIS (SCYX) United States $0.047B 0.00
India Globalization Capital (IGC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
PolarityTE (PTE) United States $0.040B 0.00
IsoRay (ISR) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
GTx (ONCT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
AgeX Therapeutics (AGE) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Neos Therapeutics (NEOS) United States $0.026B 0.00
Sundial Growers (SNDL) Canada $0.026B 0.00
Vical (BBI) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 22.27
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00